Results 181 to 190 of about 764,780 (309)

The Value of Patient-Reported Questionnaires in Detecting Ocular Surface Manifestations in Dupilumab Therapy: A Case-Control Study

open access: yesClinical Ophthalmology
Rita Teixeira-Martins,1 Célia Araújo,1,2 Ana Faria Pereira,1 Inês Coelho-Costa,1 Amândio Rocha-Sousa,1,3 Jose Luís Plácido,4 João Pinheiro-Costa,5 Mário Lima-Fontes1,3 1Department of Ophthalmology; São João Local Health Unit, Porto, Portugal; 2Faculty of
Teixeira-Martins R   +7 more
doaj  

Evaluating the impact of therapeutic drug monitoring strategies on clinical outcomes in paediatric inflammatory bowel disease

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives The increasing incidence of inflammatory bowel disease (IBD) in paediatric populations underscores the importance of effective management strategies. Anti–tumor necrosis factor (anti‐TNF) agents, such as infliximab (IFX) and adalimumab (ADL), are key treatments for inducing and maintaining remission in IBD, but many patients ...
Karlotta Pauline Hubert   +2 more
wiley   +1 more source

Upper and small bowel Crohn's disease in Brazilian children: Phenotypic characteristic and surgical risk

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Upper and small bowel Crohn's disease (U‐SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low‐ and middle‐income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U‐SBCD outcomes remains
Jane Oba   +12 more
wiley   +1 more source

Functional Characterization of a Novel Homozygous <i>DNAH5</i> Single-Nucleotide Intronic Deletion in a Consanguineous Portuguese Family with Primary Ciliary Dyskinesia. [PDF]

open access: yesCells
Hilário C   +11 more
europepmc   +1 more source

Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives 5‐Aminosalicylic acid (5‐ASA) is recommended as a first‐line medication in mild to moderate ulcerative colitis (UC), but indications regarding its use in children with moderate to severe disease treated with biologics are lacking.
Giulia D'Arcangelo   +12 more
wiley   +1 more source

Erratum: Antimicrobial stewardship at a tertiary center in Portugal: insights from prescribers - ERRATUM. [PDF]

open access: yesAntimicrob Steward Healthc Epidemiol
Valois A   +6 more
europepmc   +1 more source

Long‐term outcomes of children with ulcerative colitis after acute severe colitis: A GETAID pédiatrique multicenter study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Acute severe colitis (ASC) is a frequent and severe complication of ulcerative colitis (UC) with a high risk of colectomy. Effects of immunosuppressants and anti–tumor necrosis factor (anti‐TNF) agents on the risk of colectomy remain debated. We wished to study the evolution of French pediatric‐onset UC patients after ASC.
Manon Cochet   +18 more
wiley   +1 more source

PREM-C9 COPD patient experience questionnaire: Portuguese translation and content validity. [PDF]

open access: yesERJ Open Res
Vilarinho R   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy